Bandaram Pharma Packtech MD, chairman, board of directors and AGM
BSE: 524602Healthcare ServicesSmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹19.00.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹33 Cr3,419th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Owners' profit not stated
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 1.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- 5.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.76
- Volume, BSEVolume. Shares traded on the last trading day.
- 930
Bandaram Pharma Packtech board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- Chairperson and managing directorDEEPAK REDDY BANDARAM
- Company Secretary and Compliance OfficerNeha Kankariya
7 directors4 independent1 executive2 non-executive
- DEEPAK REDDY BANDARAM · Chairperson and managing directorExecutive · joined Feb 2023 · 1 listed board
- BHANDARAM PREMSAI REDDYNon-executive · joined Mar 2022 · 1 listed board
- BHANDARAM SATHYAVATHINon-executive · joined Mar 2022 · 1 listed board
- SURYAPRAKASA RAO BOMMISETTIIndependent · joined Mar 2022 · 54 months as independent · 3 listed boards · 3 as independent · 6 committee seats, 2 as chair
- SUMAN MALLUIndependent · joined Sep 2023 · 37 months as independent · 1 listed board · 1 as independent · 2 committee seats, 2 as chair
- ESWAR REDDY PUTTURUIndependent · joined Jan 2026 · 8 months as independent · 1 listed board · 1 as independent · 2 committee seats
- MOUNIKA PAMMIIndependent · joined Jun 2025 · 15 months as independent · 6 listed boards · 5 as independent · 10 committee seats, 1 as chair
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
4 directors who left
- NADELLA SRINIVASULA KALKI AAKARSH RAJ, left 5 Jun 2026: Others
- PRIYANKA AGARWAL, left 30 Jan 2026: Others
- Prateek Vijayvargiya, left 20 Jun 2025: Others
- VENKATA SUBRAMANYA RAJARAM CHITTULURU, left 30 May 2025: Others
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 13 Aug 20267 of 7 present4 independent · 74 days in between
- 30 May 20268 of 8 present4 independent · 56 days in between
- 3 Apr 20268 of 8 present4 independent
Audit Committee
Chair SUMAN MALLU
SURYAPRAKASA RAO BOMMISETTI, ESWAR REDDY PUTTURU
- 13 Aug 20263 of 3 present3 independent · 74 days in between
- 30 May 20263 of 3 present3 independent · 56 days in between
- 3 Apr 20263 of 3 present3 independent
Nomination and remuneration committee
Chair SUMAN MALLU
SURYAPRAKASA RAO BOMMISETTI, MOUNIKA PAMMI
- 13 Aug 20263 of 3 present3 independent
Stakeholders Relationship Committee
Chair SUMAN MALLU
SURYAPRAKASA RAO BOMMISETTI, ESWAR REDDY PUTTURU
No meeting listed in the filing.
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- M/s MM Reddy & CoPeer-review certificate valid to Mar 2028
1 earlier auditor
- M M Reddy & CoNamed in the filing for the quarter to Mar 2025
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Bandaram Pharma Packtech AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Bandaram Pharma Packtech dividend history
Annual general meeting, 24 Sep 2026
5,924 shareholders on the register on 17 Sep 2026; present: 7 promoters and 27 others; votes counted by Vivek Surana / M/s. Vivek Surana & Associates.The company's voting result (opens in a new tab)
- To consider and adopt the Audited Standalone Financial Statements for the year ended March 31, 2026 and the reports of the Board of Directors and Auditors thereon.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 75.45% · promoters 100.00% · institutions 0.00% · other public 34.26%
- To consider and adopt the Audited Consolidated Financial Statements for the year ended March 31, 2026 and the report of the Auditors thereon.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 75.45% · promoters 100.00% · institutions 0.00% · other public 34.26%
- To appoint a director in place of Mr. Bhandaram Premsai Reddy (DIN: 07170946), who retires by rotation and being eligible, offers himself for re-appointment.OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 75.45% · promoters 100.00% · institutions 0.00% · other public 34.26%
- To re-appoint M/s. M.M. Reddy & Co., Chartered Accountants (FRN No. 010371S) as Statutory Auditors of the Company.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 75.45% · promoters 100.00% · institutions 0.00% · other public 34.26%
- Re-Appointment of Mr. Suryaprakasa Rao Bommisetti (Din: 08089189) as an Independent Director of the Company.SpecialPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 75.45% · promoters 100.00% · institutions 0.00% · other public 34.26%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- Yes
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.